1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Calcium levofolinate: new trials by email Literature Review of Calcium levofolinate trials Research Report on Calcium levofolinate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06) Pembrolizumab, Sacituzumab Tirumotecan (sac-TMT), Capecitabine - Gastroesophageal Junction, Gastroesophageal Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | Merck Sharp & Dohme LLC | 160 | 2024-09-20 | 2026-10-07 |
| Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma NP137, Oxaliplatin, Irinotecan - Pancreatic Ductal Adenocarcinoma | Phase 1 | Completed | University Hospital, Grenoble | 43 | 2023-03-28 | 2026-05-19 |
Esophageal Neoplasms (1) · Parkinson Disease 4, Autosomal Dominant Lewy Body (1)
Merck Sharp & Dohme LLC (1) · University Hospital, Grenoble (1)
France (2) · Brazil (1) · Chile (1) · China (1) · Germany (1) · Italy (1) · Norway (1) · South Korea (1) · Switzerland (1) · Taiwan (1) · Thailand (1) · United States (1)
2023 (1)